Despite an 11.8% rally in 2026, BigBear.ai faces a pivotal shareholder vote that could dictate its acquisition-fueled growth strategy and test investor confidence.
The unraveling of the R&R Family of Companies is sending shockwaves through the freight industry, with a new lawsuit from Vantage Carrier alleging over $1.3 million in unpaid invoices. The case adds to a growing pile of legal claims and exposes the precarious financial exposure of carriers and small operators caught in the wake.
As Visa prepares to report its first-quarter results, investors are weighing its dividend strategy against earnings expectations. We break down the capital required to generate targeted monthly income from its payouts and what moving parts could affect the yield.
Gulfport Energy (NYSE: GPOR) shares have surged roughly 200% over three years, yet a deep dive reveals conflicting signals. While a cash flow model suggests significant undervaluation, its price-to-sales ratio tells a more cautious tale, leaving investors to weigh the metrics against a volatile energy backdrop.
Galderma Group's (SWX:GALD) shares have faced significant pressure in recent months, contrasting sharply with its strong yearly performance. This analysis delves into whether the current valuation presents a genuine entry point or reflects deeper concerns about the dermatology giant's ambitious growth narrative.
RH shares have cratered over 50% in the past year, battered by concerns over high-end consumer spending. While a key valuation model suggests the luxury home furnishing retailer is deeply undervalued, its premium earnings multiple tells a conflicting story, leaving investors to question if this is a buying opportunity or a sign of deeper troubles.
Barrick Gold (TSX:ABX) has delivered staggering returns of over 150% in five years, leaving investors to question if the rally has run its course. A deep dive into valuation models suggests the stock may still be trading at a significant discount to its intrinsic value.
Fair Isaac Corporation (FICO) shares have retreated from recent highs, prompting investors to reassess the valuation of the credit-scoring giant. With the stock down over 13% in the past month, we examine whether the dip presents a strategic entry point or confirms concerns that the rally has run its course.
Canadian National Railway is ramping up capital returns to shareholders through a significant new share repurchase program and a dividend increase, as the rail giant seeks to reassure investors following a period of underperformance in its stock price.
Defense giant Lockheed Martin secures a pivotal seven-year agreement to dramatically ramp up production of key missile defense systems while launching a new venture aimed at combating wildfires, signaling a dual-track strategy of reinforcing core government business and diversifying into civilian applications.
Google's parent company unveils an AI-powered tool for generating interactive 3D worlds, signaling a strategic push into the core technology of game development and virtual experiences, with potential ripple effects across content creation and cloud infrastructure.
In a major strategic shift, uranium-focused Energy Fuels announces a deal to acquire Australian Strategic Materials, aiming to create a vertically integrated rare earths producer outside China. The move comes as the company's stock, already on a meteoric rise, faces new questions about its growth trajectory and valuation.
Shares of Occidental Petroleum (OXY) have rallied roughly 10% over the last quarter, reigniting investor interest. As the oil giant aggressively pursues its Direct Air Capture ventures, analysts are divided on whether the current price of $45.39 reflects its true worth or overlooks significant long-term potential.
Terex Corporation's shares have experienced notable swings, declining over 4% last week but gaining nearly 7% in the past month. A fresh look at its valuation through discounted cash flow and peer comparisons suggests the stock may be trading at a significant discount to its intrinsic value.
Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) have surged over 50% in the last three months, reigniting debate over its fair value and the risks tied to its lead drug OJEMDA and a pivotal upcoming data readout.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
Bloom Energy's landmark $2.65 billion power agreement and a potential $5 billion infrastructure partnership signal a strategic pivot to become a cornerstone provider for the energy-hungry AI data center industry, prompting a fresh look at its long-term valuation.
The stablecoin issuer finished 2025 with over $10 billion in net profit, backed by a $17.4 billion gold reserve and a U.S. Treasury portfolio that rivals major nations, as demand for its USDT token continues to surge globally.
As Nvidia's Blackwell and Rubin chips push power densities to unprecedented levels, the $4 trillion AI revolution faces a formidable physical constraint: heat. Vertiv Holdings, a critical infrastructure provider, is emerging as an essential player in solving this thermal challenge, with surging demand signaling a major shift in data center economics.
Chevron CEO Mike Wirth signals the energy giant could significantly ramp up processing of Venezuelan crude at its U.S. refineries, following a pivotal Treasury Department license that eases trade restrictions with Caracas.
